Discover
SYRE
Spyre Therapeutics, Inc.
88.89
2 x 64.80
2 x 111.52
bid
ask
+
0.11
0.12%
2 @ 04:00 PM
89.83 +0.94 (1.05%)
| Ytd | 171.34% | |
| 1y | 473.85% |
86.87
day range
89.02
14.51
52 week range
102.06
| Open | 87.30 | Prev Close | 88.78 | Low | 86.87 | High | 89.02 | Mkt Cap | 7.72B |
| Vol | 1.44M | Avg Vol | 1.44M | EPS | -2.12 | P/E | N/A | Forward P/E | -28.41 |
| Beta | 3.06 | Short Ratio | 11.85 | Inst. Own | 93.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 76.98 | 200-d Avg | 43.87 | 1yr Est | 100.47 |
| Income Statement | |||
| Operating Expenses | 45.64M | ||
| Research and Development Expense | 60.41M | ||
| Selling, General and Administrative Expense | 15.23M | ||
| Operating Income | -45.64M | ||
| Net Income | -69.00M | ||
| Net Income Common Stock | -69.00M | ||
| Net Income Common Stock (USD) | -69.00M | ||
| Consolidated Income | -69.00M | ||
| Earnings per Basic Share | -0.74 | ||
| Earnings per Basic Share (USD) | -0.74 | ||
| Earnings per Diluted Share | -0.74 | ||
| Earning Before Interest & Taxes (EBIT) | -69.00M | ||
| Earning Before Interest & Taxes (USD) | -69.00M | ||
| Weighted Average Shares | 78.55M | ||
| Weighted Average Shares Diluted | 78.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 97.19M | ||
| Cash and Equivalents (USD) | 97.19M | ||
| Investments | 644.28M | ||
| Investments Current | 644.28M | ||
| Current Assets | 763.95M | ||
| Total Assets | 763.95M | ||
| Current Liabilities | 85.16M | ||
| Total Liabilities | 93.14M | ||
| Accumulated Retained Earnings (Deficit) | -1.20B | ||
| Accumulated Other Comprehensive Income | -767.00K | ||
| Shareholders Equity | 670.81M | ||
| Shareholders Equity (USD) | 670.81M | ||
| Liabilities Non-Current | 7.98M | ||
| Trade and Non-Trade Payables | 5.74M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 12.26M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.46M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 30.00M | ||
| Issuance (Purchase) of Equity Shares | 12.43M | ||
| Net Cash Flow from Investing | 56.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 26.58M | ||
| Net Cash Flow from Operations | -57.37M | ||
| Share Based Compensation | 12.81M | ||